Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-03-19

Clinical Trial Update: VRC 313: A Trivalent Virus-like Particle (VLP) Encephalitis Vaccine (WEVEE) in Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating a trivalent VLP vaccine (WEVEE) for Venezuelan, Western, and Eastern Equine Encephalitis in healthy adults has completed with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • WEVEE (trivalent virus-like particle encephalitis vaccine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Venezuelan Equine Encephalitis, Western Equine Encephalitis | Phase 1 | Status: COMPLETED | Results posted: 2021-03-19